ADR databases for on‐site clinical use: Potentials of summary of products characteristics-Reference-Cited by-同舟云学术

ADR databases for on‐site clinical use: Potentials of summary of products characteristics

Published:2021-02-24 Issue:4 Volume:128 Page:557-567
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin. Pharmacol. Toxicol.

Author:

Eiermann Birgit¹²^ORCID,Rodriguez Daniel³,Cohen Paul³,Gustafsson Lars L.¹³^ORCID

Affiliation:

1. Department of Laboratory Medicine Division of Clinical Pharmacology Karolinska Institutet Karolinska University Hospital Stockholm Sweden

2. Inera ABSwedish Association of Local Authorities and Regions Stockholm Sweden

3. Swedish Institute for Drug Informatics (SIDI) Division of Clinical Pharmacology Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Funder

Karolinska Institutet

Vetenskapsrådet

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13564

Reference28 articles.

1. Safety of medicines: a guide to detecting and reporting adverse drug reactions. [PDF] 2002 03/24/2012].http://whqlibdoc.who.int/hq/2002/WHO_EDM_QSM_2002.2.pdf. Accessed 19 August 2020.

2. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability

3. Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers

4. e-SPC - delivering drug information in the 21st century: developing new approaches to deliver drug information to prescribers

5. Shaping medicinal product information: a before and after study exploring physicians’ perspectives on the summary of product characteristics